Why We Built KORECOA
The peptide industry has a geography problem. The compounds are made in Asia. The testing labs are in the West. That means every independent COA requires shipping samples across the Pacific or Atlantic, clearing customs twice, waiting weeks for results, and hoping nothing degrades in transit.
We asked a simple question: why not test where the peptides already are?
South Korea sits at the crossroads of Asia's pharmaceutical supply chain. It has world-class analytical infrastructure, one of Asia's most stringent regulatory frameworks (MFDS), and direct logistics connections to every major manufacturing hub in China and India. A sample that takes 14 days to reach a US lab arrives in Seoul in 2–3 days.
KORECOA was founded to turn that geographic advantage into a verification standard. We partner with multiple accredited Korean laboratories, each specializing in different analytical methods — HPLC, LC-MS/MS, SEC-HPLC, ICP-MS — and route each sample to the optimal facility based on compound type and required testing.
The result is the VerifyKorea standard: an independently verified COA issued from a neutral, MFDS-regulated jurisdiction, delivered before your peptides ever leave Asia.